A randomised comparison of deferasirox versus deferoxamine for the treatment of transfusional iron overload in sickle cell disease
Vichinsky, Elliott, Onyekwere, Onyinye, Porter, John, Swerdlow, Paul, Eckman, James, Lane, Peter, Files, Beatrice, Hassell, Kathryn, Kelly, Patrick, Wilson, Felicia, Bernaudin, Françoise, Forni, Gian Luca, Okpala, Iheanyi, Ressayre‐Djaffer, Catherine, Alberti, Daniele, Holland, Jaymes, Marks, Peter, Fung, Ellen, Fischer, Roland, Mueller, Brigitta U., Coates, Thomas
Published in British journal of haematology (01.02.2007)
Published in British journal of haematology (01.02.2007)
Get full text
Journal Article
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with β-thalassemia
Cappellini, Maria Domenica, MD, Bejaoui, Mohamed, MD, Agaoglu, Leyla, MD, Porter, John, MD, Coates, Thomas, MD, Jeng, Michael, MD, Lai, Maria Eliana, MD, Mangiagli, Antonio, MD, Strauss, Gabriele, MD, Girot, Robert, MD, Watman, Nora, MD, Ferster, Alina, MD, Loggetto, Sandra, MD, Abish, Sharon, MD, Cario, Holger, MD, Zoumbos, Nicolaos, MD, Vichinsky, Elliott, MD, Opitz, Herbert, MD, Ressayre-Djaffer, Catherine, PhD, Abetz, Linda, MA, Rofail, Diana, MSc, Baladi, Jean-Francois, MBA
Published in Clinical therapeutics (01.05.2007)
Published in Clinical therapeutics (01.05.2007)
Get full text
Journal Article
A phase 3 study of deferasirox (ICL670), a once-daily oral iron chelator, in patients with β-thalassemia
Cappellini, Maria Domenica, Cohen, Alan, Piga, Antonio, Bejaoui, Mohamed, Perrotta, Silverio, Agaoglu, Leyla, Aydinok, Yesim, Kattamis, Antonis, Kilinc, Yurdanur, Porter, John, Capra, Marcello, Galanello, Renzo, Fattoum, Slaheddine, Drelichman, Guillermo, Magnano, Carmelo, Verissimo, Monica, Athanassiou-Metaxa, Miranda, Giardina, Patricia, Kourakli-Symeonidis, Alexandra, Janka-Schaub, Gritta, Coates, Thomas, Vermylen, Christiane, Olivieri, Nancy, Thuret, Isabelle, Opitz, Herbert, Ressayre-Djaffer, Catherine, Marks, Peter, Alberti, Daniele
Published in Blood (01.05.2006)
Published in Blood (01.05.2006)
Get full text
Journal Article
Semi-Quantitative Assessment of Hemosiderin Distribution Accurately Reflects Reductions in Liver Iron Concentration Following Therapy with Deferasirox (Exjade®, ICL670) or Deferoxamine in Patients with Transfusion-Dependent Anemia
Deugnier, Yves, Turlin, Bruno, Ropert, Martine, Bejaoui, Mohamed, Athanassiou-Metaxa, Miranda, Cario, Holger, Vichinsky, Elliott, Opitz, Herbert, Ressayre-Djaffer, Catherine, Rabault, Bertrand, Ford, John
Published in Blood (16.11.2005)
Published in Blood (16.11.2005)
Get full text
Journal Article
Phase III Evaluation of Once-Daily, Oral Therapy with ICL670 (Exjade®) Versus Deferoxamine in Patients with β-Thalassemia and Transfusional Hemosiderosis
Cappellini, Maria, Bejaoui, Mohamed, Perrotta, Silverio, Agaoglu, Leyla, Kattamis, Antonios, Giardina, Patricia, Janka-Schaub, Gritta, Opitz, Herbert, Ressayre-Djaffer, Catherine, Alberti, Daniele
Published in Blood (16.11.2004)
Published in Blood (16.11.2004)
Get full text
Journal Article
Prospective evaluation of patient-reported outcomes during treatment with deferasirox or deferoxamine for iron overload in patients with [beta]-thalassemia
Cappellini, Maria Domenica, Bejaoui, Mohamed, Agaoglu, Leyla, Porter, John, Coates, Thomas, Jeng, Michael, Lai, Maria Eliana, Mangiagli, Antonio, Strauss, Gabriele, Girot, Robert, Watman, Nora, Ferster, Alina, Loggetto, Sandra, Abish, Sharon, Cario, Holger, Zoumbos, Nicolaos, Vichinsky, Elliott, Opitz, Herbert, Ressayre-Djaffer, Catherine, Abetz, Linda, Rofail, Diana, Baladi, Jean-Francois
Published in Clinical therapeutics (01.05.2007)
Published in Clinical therapeutics (01.05.2007)
Get full text
Journal Article